Viewing data from:

PENICILLIN G PROCAINE

ANDA

PENICILLIN G PROCAINE | A060099 | PFIZER LABORATORIES DIV PFIZER INC

2 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Penicillin G Procaine (2023)

Total Spending

$10K

Total Claims

Beneficiaries

Avg Cost/Unit

$40.39

Spending Trend

$22K(2019)→$22K(2020)→$19K(2021)→$31K(2022)→$10K(2023)

YoY Change:+15.1%

5yr CAGR:+10.5%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain0 active DMFs9 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

GIST-BROCADES NV PHARMACEUTICALSInactivePENICILLIN G PROCAINE

DMF 131981998

BIOCHEMIE DEUTSCHLAND GMBHInactivePENICILLIN G PROCAINE STERILE

DMF 132031998

ELI LILLY AND COInactivePENICILLIN G PROCAINE

DMF 132911998

PFIZER INCInactivePENICILLIN G PROCAINE

DMF 133191998

WYETH-AYERST LABORATORIESInactivePENICILLIN G PROCAINE

DMF 133271998

ANKERFARM SPAInactivePENICILLIN G PROCAINE

DMF 135171998

MEIJI SEIKA KAISHA LTDInactivePENICILLIN G PROCAINE

DMF 135351998

GIST-BROCADES NV PHARMACEUTICALSInactivePENICILLIN G PROCAINE

DMF 135391998

BIOTIKA ASInactivePENICILLIN G PROCAINE

DMF 144001999

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 300,000 UNITS/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — 1,500,000 UNITS/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982